Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications ; volume:24 ; number:6 ; day:13 ; month:8 ; year:2024 ; pages:729-741 ; date:11.2024
American journal of cardiovascular drugs ; 24, Heft 6 (13.8.2024), 729-741, 11.2024
- Urheber
-
Bertolet, Barry D.
Cabral, Katherine P.
Sullenberger, Lance
McAlister, Jan L.
Sandroni, Todd
Patel, Dharmesh S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40256-024-00665-1
- URN
-
urn:nbn:de:101:1-2501192108068.960757088834
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bertolet, Barry D.
- Cabral, Katherine P.
- Sullenberger, Lance
- McAlister, Jan L.
- Sandroni, Todd
- Patel, Dharmesh S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation